[LGND] QoQ Quarter Result on 31-Dec-2018 [#Q4]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
28-Feb-2019
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- -163.07%
YoY- -506.02%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Revenue 24,808 24,987 43,484 59,590 45,663 90,043 56,157 -41.96%
PBT -19,871 -18,028 842,713 -56,789 79,226 95,579 55,312 -
Tax -4,620 -3,609 176,376 -14,307 11,864 22,419 10,033 -
NP -15,251 -14,419 666,337 -42,482 67,362 73,160 45,279 -
Tax Rate - - -20.93% - -14.97% -23.46% -18.14% -
Total Cost 40,059 39,406 -622,853 102,072 -21,699 16,883 10,878 138.28%
Ratio Analysis
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
NP Margin -61.48 -57.71 1,532.37 -71.29 147.52 81.25 80.63 -
Per Share
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
EPS -0.81 -0.74 32.59 -2.02 3.19 3.45 2.13 -
EPS Diluted -0.81 -0.74 31.32 -2.02 2.80 2.99 1.83 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.